Conmed (CNMD) Total Liabilities (2010 - 2026)

Conmed has reported Total Liabilities for 17 years, with the latest figure at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 1.73% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (down 1.73% YoY), and the FY2025 full-year result was $1.3 billion, down 3.79% from the prior year.
• Total Liabilities for Q1 2026 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
• The five-year high for Total Liabilities was $1.6 billion in Q3 2022, with the low at $996.2 million in Q1 2022.
• Historically, Total Liabilities has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2022.
• Annual changes were most pronounced in 2022 — Total Liabilities jumped 58.28% — and 2024, when it decreased 9.59%.
• Conmed's Total Liabilities stood at $1.6 billion in 2022, then declined by 5.56% to $1.5 billion in 2023, then dropped by 8.34% to $1.3 billion in 2024, then retreated by 3.79% to $1.3 billion in 2025, then rose by 0.36% to $1.3 billion in 2026.
• The last three Total Liabilities figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.